SLRX - Salarius Pharmaceuticals GAAP EPS of -$3.84 March, 22 2024 04:17 PM Salarius Pharmaceuticals Inc. 2024-03-22 16:17:56 ET More on Salarius Pharmaceuticals Salarius's CEO David Arthur steps down Seeking Alpha’s Quant Rating on Salarius Pharmaceuticals Financial information for Salarius Pharmaceuticals For further details see: Salarius Pharmaceuticals GAAP EPS of -$3.84